DFTX vs TLRY: stock comparison and AI forecast
Definium Therapeutics, Inc. (DFTX) and Tilray Brands, Inc. (TLRY) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
DFTX Definium Therapeutics, Inc.
- Price
- $33.27 +43.4% · 6M
- Market Cap
- $4.47B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
TLRY Tilray Brands, Inc.
- Price
- $2.92 -48.4% · 6M
- Market Cap
- $432M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- DFTX is 10.4 times larger than TLRY by market capitalization ($4.47B against $432M).
- Over the last six months DFTX returned +43.4% and TLRY -48.4%.
- TLRY carries 0.44 times debt per unit of equity, against 0.21 times for DFTX.
- Both companies share the SEC industry classification Medicinal Chemicals & Botanical Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | DFTX | TLRY |
|---|---|---|
| Market Cap | $4.47B | $432M |
| P/B Ratio | 4.87x | 0.27x |
| EPS | $-3.00 | $-1.41 |
| Book Value/Share | $6.84 | $10.98 |
| Revenue/Share | – | $6.52 |
Profitability & Margins
| Metric | DFTX | TLRY |
|---|---|---|
| ROE | -38.5% | -10.1% |
| ROA | -31.8% | -7.0% |
| ROIC | -23.8% | -4.7% |
| Gross Margin | – | 29.1% |
| Operating Margin | – | -9.3% |
| Net Margin | – | -17.1% |
| EBT Margin | – | -13.0% |
| Tax Rate | – | -16.8% |
Financial Health
| Metric | DFTX | TLRY |
|---|---|---|
| Current Ratio | 6.95x | 1.88x |
| Quick Ratio | – | 1.11x |
| D/E Ratio | 0.21x | 0.44x |
| Financial Leverage | 1.21x | 1.43x |
| Interest Coverage | -60.9x | -0.6x |
| Working Capital | $935M | $377M |
Cash Flow
| Metric | DFTX | TLRY |
|---|---|---|
| Operating Cash Flow | -$168M | -$84M |
Operational Efficiency
| Metric | DFTX | TLRY |
|---|---|---|
| Asset Turnover | – | 0.41x |
| Receivables Turnover | – | 5.0x |
| Inventory Turnover | – | 2.1x |
| Fixed Assets Turnover | – | 1.4x |
| Days Sales Outstanding | – | 72 days |
| Days Inventory | – | 176 days |
| Payables Period | – | 71 days |
| Cash Conversion Cycle | – | 177 days |
Income Statement
| Metric | DFTX | TLRY |
|---|---|---|
| Total Revenue | – | $963M |
| Operating Income | -$228M | -$89M |
| Net Income | -$354M | -$164M |
| R&D Expense | $155M | $410K |
| SG&A Expense | – | $270M |
| Cost of Goods Sold | – | $683M |
Dividend & Shareholder Information
| Metric | DFTX | TLRY |
|---|---|---|
| Shares Outstanding | 134M | 148M |
DFTX vs TLRY: stock comparison and AI forecast
Which is bigger, DFTX or TLRY?
DFTX is 10.4 times larger than TLRY by market capitalization ($4.47B against $432M).
Which stock performed better over the last six months, DFTX or TLRY?
Over the last six months DFTX returned +43.4% and TLRY -48.4%.
Which one does Intratio's AI model rank higher, DFTX or TLRY?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.